{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05971823",
            "orgStudyIdInfo": {
                "id": "HM20025464"
            },
            "secondaryIdInfos": [
                {
                    "id": "2U54DA036105",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/2U54DA036105"
                }
            ],
            "organization": {
                "fullName": "Virginia Commonwealth University",
                "class": "OTHER"
            },
            "briefTitle": "Effects of Electronic Cigarette Flavors on Abuse Liability in Smokers (P3-Taste)",
            "officialTitle": "Effects of Electronic Cigarette Flavors on Abuse Liability in Smokers (P3-Taste)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "effects-of-electronic-cigarette-flavors-on-abuse-liability-in-smokers-taste"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-07-31",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-08-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-08-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-07-14",
            "studyFirstSubmitQcDate": "2023-07-31",
            "studyFirstPostDateStruct": {
                "date": "2023-08-02",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-08-17",
            "lastUpdatePostDateStruct": {
                "date": "2023-08-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Virginia Commonwealth University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute on Drug Abuse (NIDA)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to determine if abuse liability indices will be impacted by varying flavors and e-cigarette (ECIG) nicotine delivery capability (i.e., nicotine flux) among current combustible cigarette users.\n\nThe investigators will compare abuse liability indices between three FDA-authorized ECIG products that vary in nicotine flux (but are all tobacco flavor) and own brand cigarettes. The investigators will also test the influence of ECIG flavor availability (tobacco vs. menthol) within three ECIG product classes."
        },
        "conditionsModule": {
            "conditions": [
                "Electronic Cigarette Use"
            ],
            "keywords": [
                "Electronic Cigarette",
                "Nicotine Flux",
                "Tobacco Use"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "interventionModelDescription": "Participants will complete 4, within-subject, laboratory sessions that differ by the product used: 1) own brand cigarette, 2) NJOY Ace 2.4% nicotine ECIG (Menthol and Classic Tobacco flavor), 3) NJOY Ace 5.0% nicotine ECIG (Menthol and Classic Tobacco flavor), and 4) NJOY Daily ECIG 6% nicotine (Menthol and Extra Rich Tobacco). The first condition for all participants will be their own brand cigarette. The subsequent three sessions will be assigned using a Latin-square following enrollment, and within each session participants will sample and evaluate two flavors of each session's product (session flavor order is incorporated into the Latin-square condition order assignment).",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "maskingDescription": "Participants will be blinded to device nicotine concentration and flavor used during ECIG sessions. No blinding will occur for the own brand condition.",
                    "whoMasked": [
                        "PARTICIPANT"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 36,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Own Brand Cigarette",
                    "type": "ACTIVE_COMPARATOR",
                    "interventionNames": [
                        "Other: Tobacco product administration and assessment"
                    ]
                },
                {
                    "label": "NJOY Ace 2.4% nicotine ECIG - Menthol flavor",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Other: Tobacco product administration and assessment"
                    ]
                },
                {
                    "label": "NJOY Ace 2.4% nicotine ECIG - Classic Tobacco flavor",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Other: Tobacco product administration and assessment"
                    ]
                },
                {
                    "label": "NJOY Ace 5.0% nicotine ECIG - Menthol flavor",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Other: Tobacco product administration and assessment"
                    ]
                },
                {
                    "label": "NJOY Ace 5.0% nicotine ECIG - Classic Tobacco flavor",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Other: Tobacco product administration and assessment"
                    ]
                },
                {
                    "label": "NJOY Daily 6.0% nicotine ECIG - Menthol flavor",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Other: Tobacco product administration and assessment"
                    ]
                },
                {
                    "label": "NJOY Daily 6.0% nicotine ECIG - Extra Rich Tobacco flavor",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Other: Tobacco product administration and assessment"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Tobacco product administration and assessment",
                    "description": "Subjective measures 1 is followed by product sampling that includes 5 self-directed ECIG/own brand cigarette puffs over 10 minutes. After sampling is complete participants complete subjective measures 2. Ten minutes after their sampling has been completed, they complete subjective measures 3 and the behavioral economic task(s). These activities are preceded and followed by cardiovascular response assessment.",
                    "armGroupLabels": [
                        "NJOY Ace 2.4% nicotine ECIG - Classic Tobacco flavor",
                        "NJOY Ace 2.4% nicotine ECIG - Menthol flavor",
                        "NJOY Ace 5.0% nicotine ECIG - Classic Tobacco flavor",
                        "NJOY Ace 5.0% nicotine ECIG - Menthol flavor",
                        "NJOY Daily 6.0% nicotine ECIG - Extra Rich Tobacco flavor",
                        "NJOY Daily 6.0% nicotine ECIG - Menthol flavor",
                        "Own Brand Cigarette"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Breakpoint of Drug Purchase Task (DPT)",
                    "description": "The DPTs will yield measures of willingness to pay and measures of price sensitivity for session-specific tobacco products. Choices made during this task are not reinforced during the session.",
                    "timeFrame": "Each DPT will be completed twice per study session, about 55 minutes into the session and again at 120 minutes into the session"
                },
                {
                    "measure": "Elasticity of Drug Purchase Task (DPT)",
                    "description": "The DPTs will yield measures of willingness to pay and measures of price sensitivity for session-specific tobacco products. Choices made during this task are not reinforced during the session.",
                    "timeFrame": "Each DPT will be completed twice per study session, about 55 minutes into the session and again at 120 minutes into the session"
                },
                {
                    "measure": "Omax of Drug Purchase Task (DPT)",
                    "description": "The DPTs will yield measures of willingness to pay and measures of price sensitivity for session-specific tobacco products. Choices made during this task are not reinforced during the session.",
                    "timeFrame": "A DPT will be Each DPT will be completed twice per study session, about 55 minutes into the session and again at 120 minutes into the session once for each arm."
                },
                {
                    "measure": "Pmax of Drug Purchase Task (DPT)",
                    "description": "The DPTs will yield measures of willingness to pay and measures of price sensitivity for session-specific tobacco products. Choices made during this task are not reinforced during the session.",
                    "timeFrame": "Each DPT will be completed twice per study session, about 55 minutes into the session and again at 120 minutes into the session"
                },
                {
                    "measure": "Intensity of Drug Purchase Task (DPT)",
                    "description": "The DPTs will yield measures of willingness to pay and measures of price sensitivity for session-specific tobacco products. Choices made during this task are not reinforced during the session.",
                    "timeFrame": "Each DPT will be completed twice per study session, about 55 minutes into the session and again at 120 minutes into the session"
                },
                {
                    "measure": "Cross-price elasticity of the Cross Product-DPT",
                    "description": "The Cross Product (CP)-DPTs assess cross-product purchasing behaviors between various tobacco products offered at a fixed amount and own brand cigarettes offered at varying prices.",
                    "timeFrame": "Each CP-DPT will be completed twice per study session, about 55 minutes into the session and again at 120 minutes into the session"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Subjective measures of nicotine withdrawal",
                    "description": "Nicotine withdrawal will be measured using the Adapted Minnesota Nicotine Withdrawal Scale (MNWS), higher numbers indicate more nicotine dependence.",
                    "timeFrame": "Up to 55 minutes (session 1) and up to 120 minutes (sessions 2-4) into the session"
                },
                {
                    "measure": "Subjective measures of nicotine side effects",
                    "description": "Nicotine side effects will be measured using the Direct Effects of Nicotine Scale (DENS), higher scores indicate more intense nicotine side effects.",
                    "timeFrame": "Up to 55 minutes (session 1) and up to 120 minutes (sessions 2-4) into the session"
                },
                {
                    "measure": "Subjective measures of product effects",
                    "description": "Product effects will be measured using Direct Effects of Tobacco VAS Scale, higher scores indicate more intense product effects.",
                    "timeFrame": "Up to 55 minutes (session 1) and up to 120 minutes (sessions 2-4) into the session"
                },
                {
                    "measure": "General Labeled Magnitude Scale",
                    "description": "Perceptions of electronic cigarette effects will be measured using the General Labeled Magnitude Scale (gLms), higher scores indicate stronger perceptions of nicotine effects.",
                    "timeFrame": "Up to 55 minutes (session 1) and up to 120 minutes (sessions 2-4) into the session"
                },
                {
                    "measure": "Labeled Hedonic Scale",
                    "description": "Labeled Hedonic Scale measures nicotine abstinence symptoms, higher scores indicate higher abstinence symptoms",
                    "timeFrame": "Up to 55 minutes (session 1) and up to 120 minutes (sessions 2-4) into the session"
                },
                {
                    "measure": "Change in Heart Rate",
                    "description": "Heart rate (measured in bpm)",
                    "timeFrame": "Recorded throughout each 1 hour and 10 minutes/2 hour and 15 minute study session using automated software every 10 seconds."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* healthy (determined by self-report)\n* at least 18 years old\n* willing to provide informed consent\n* able to attend the lab and use designated products according to study protocol\n* smoke cigarettes at least 3 days per week and on those days at least 1 cigarette smoked per day\n* positive urine cotinine test\n\nExclusion Criteria:\n\n* Women if they are breast-feeding or test positive for pregnancy (by urinalysis) at screening.\n* Some study details about the eligibility criteria are purposely omitted at this time to preserve scientific integrity. Full details will be posted at the conclusion of the study.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "55 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Caroline O Cobb, PhD",
                    "role": "CONTACT",
                    "phone": "804-827-3562",
                    "email": "cobbco@vcu.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Caroline O Cobb, PhD",
                    "affiliation": "Virginia Commonwealth University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Andrew Barnes, PhD",
                    "affiliation": "Virginia Commonwealth University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Center for the Study of Tobacco Products",
                    "status": "RECRUITING",
                    "city": "Richmond",
                    "state": "Virginia",
                    "zip": "23220",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Caroline Cobb, PhD",
                            "role": "CONTACT",
                            "phone": "804-827-3562",
                            "email": "cstp@vcu.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.55376,
                        "lon": -77.46026
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M12478",
                    "name": "Nicotine",
                    "relevance": "LOW"
                },
                {
                    "id": "M11591",
                    "name": "Menthol",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Derm",
                    "name": "Dermatologic Agents"
                }
            ]
        }
    },
    "hasResults": false
}